Adaptive Biotechnologies Corp
ADPT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001478320
In the last 90 days, Adaptive Biotechnologies Corp insiders filed 0 open-market purchases and 13 sales; 301 institutions reported holding it in 13F filings for Q2 2026, worth $3.34B in total; superinvestors Viking Global Investors and ARK Invest hold it.
Q2 2025 vs. Q1 2025
How the institutions holding Adaptive Biotechnologies Corp changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 225 | 3 | 242 | +20 |
| Shares | 152.9M | 81.4K | 148.2M | −4.67M (−3.1%) |
| Value | $1.14B | $605.1K | $1.73B | +$590.6M (+52.0%) |
3 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (46)
Institutions that held Adaptive Biotechnologies Corp at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (26)
Institutions that held Adaptive Biotechnologies Corp at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Perceptive Advisors LLC | 930,972 | $6.92M |
| Clearline Capital LP | 586,380 | $4.36M |
| Brevan Howard Capital Management LP | 60,213 | $447.4K |
| Corebridge Financial, Inc. | 56,742 | $421.6K |
| EntryPoint Capital, LLC | 50,352 | $374.1K |
| Jane Street Group, LLC | 43,272 | $321.5K |
| Alpha Wealth Funds, LLC | 40,000 | $297.2K |
| Guggenheim Capital LLC | 34,497 | $256.3K |
| HSBC Holdings PLC | 34,571 | $256.2K |
| SIH Partners, LLLP | 22,113 | $164.3K |
| Graham Capital Management, L.P. | 17,669 | $131.3K |
| Teza Capital Management LLC | 15,899 | $118.1K |
| TownSquare Capital, LLC | 12,818 | $95.2K |
| Caxton Associates LLP | 12,475 | $92.7K |
| Candriam Luxembourg S.C.A. | 12,058 | $89.6K |
| Personal Cfo Solutions, LLC | 11,250 | $83.6K |
| Wexford Capital LP | 11,197 | $83.2K |
| Quadrant Capital Group LLC | 9,635 | $71.6K |
| KBC Group NV | 8,378 | $62.0K |
| Amundi | 4,531 | $33.6K |
| Coldstream Capital Management Inc | 1,655 | $12.3K |
| Quent Capital, LLC | 1,202 | $8.93K |
| Simplex Trading, LLC | 963 | $7.00K |
| Boston Private Wealth LLC | 149 | $1.11K |
| Rise Advisors, LLC | 119 | $884 |
| Stephens Consulting, LLC | 45 | $335 |
Not filed for Q2 2025 yet (3)
Institutions that held Adaptive Biotechnologies Corp at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Rappaport Reiches Capital Management, LLC | 69,075 | $513.2K |
| CAPROCK Group, Inc. | 10,944 | $81.3K |
| Lindbrook Capital, LLC | 1,416 | $10.5K |